Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II - PubMed (original) (raw)
Clinical Trial
Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II
M Mavissakalian et al. Am J Psychiatry. 1985 May.
Abstract
The authors explored the relationship between the antiobsessional and antidepressant effects of tricyclic drugs in primary obsessive-compulsive disorders. Study 1 consisted of a controlled 12-week trial with clomipramine (N = 7) and placebo (N = 5); study 2 analyzed the pooled data from 15 patients uniformly selected and treated with either clomipramine or imipramine. Although the antiobsessional and antidepressant effects of the drugs covaried, their antidepressant action was not a prerequisite for their antiobsessional effect. The findings suggest that clomipramine and probably imipramine possess specific antiobsessive effects that are at least partially independent of their antidepressant effects.
Similar articles
- Tricyclic antidepressants in obsessive-compulsive disorder. Antiobsessional or antidepressant agents?
Mavissakalian M, Michelson L. Mavissakalian M, et al. J Nerv Ment Dis. 1983 May;171(5):301-6. doi: 10.1097/00005053-198305000-00007. J Nerv Ment Dis. 1983. PMID: 6343556 Clinical Trial. - Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
Insel TR, Murphy DL, Cohen RM, Alterman I, Kilts C, Linnoila M. Insel TR, et al. Arch Gen Psychiatry. 1983 Jun;40(6):605-12. doi: 10.1001/archpsyc.1983.04390010015002. Arch Gen Psychiatry. 1983. PMID: 6342562 Clinical Trial. - Effects of imipramine on depression and obsessive-compulsive symptoms.
Foa EB, Steketee G, Kozak MJ, Dugger D. Foa EB, et al. Psychiatry Res. 1987 Jun;21(2):123-36. doi: 10.1016/0165-1781(87)90070-9. Psychiatry Res. 1987. PMID: 3615688 Clinical Trial. - Clomipramine: an antiobsessional tricyclic antidepressant.
Peters MD 2nd, Davis SK, Austin LS. Peters MD 2nd, et al. Clin Pharm. 1990 Mar;9(3):165-78. Clin Pharm. 1990. PMID: 2180623 Review. - Drug treatment of obsessive-compulsive disorder.
Zohar J, Insel TR. Zohar J, et al. J Affect Disord. 1987 Sep-Oct;13(2):193-202. doi: 10.1016/0165-0327(87)90023-1. J Affect Disord. 1987. PMID: 2960711 Review.
Cited by
- Serotonin selectivity for obsessive compulsive and panic disorders.
Montgomery SA, Bullock T, Fineberg N. Montgomery SA, et al. J Psychiatry Neurosci. 1991 Jul;16(2 Suppl 1):30-5. J Psychiatry Neurosci. 1991. PMID: 1931935 Free PMC article. Review. No abstract available. - Management of obsessive-compulsive disorder with fluvoxamine extended release.
Ordacgi L, Mendlowicz MV, Fontenelle LF. Ordacgi L, et al. Neuropsychiatr Dis Treat. 2009;5:301-8. doi: 10.2147/ndt.s3301. Epub 2009 Jun 10. Neuropsychiatr Dis Treat. 2009. PMID: 19557140 Free PMC article. - Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis.
Skapinakis P, Caldwell DM, Hollingworth W, Bryden P, Fineberg NA, Salkovskis P, Welton NJ, Baxter H, Kessler D, Churchill R, Lewis G. Skapinakis P, et al. Lancet Psychiatry. 2016 Aug;3(8):730-739. doi: 10.1016/S2215-0366(16)30069-4. Epub 2016 Jun 16. Lancet Psychiatry. 2016. PMID: 27318812 Free PMC article. Review. - The brain in obsessive-compulsive disorder.
McGuire PK. McGuire PK. J Neurol Neurosurg Psychiatry. 1995 Nov;59(5):457-9. doi: 10.1136/jnnp.59.5.457. J Neurol Neurosurg Psychiatry. 1995. PMID: 8530924 Free PMC article. No abstract available. - Current concepts in the pharmacological treatment of obsessive-compulsive disorder.
Zohar J, Zohar-Kadouch RC, Kindler S. Zohar J, et al. Drugs. 1992 Feb;43(2):210-8. doi: 10.2165/00003495-199243020-00007. Drugs. 1992. PMID: 1372219 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical